Boehringer Ingelheim

Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
PR-USA
Sat, 12/11/10 - 12:57 pm
Afatinib
breast cancer
Boehringer Ingelheim
Bayer, Boehringer, Novartis vie for vet ops-sources
Reuters
Thu, 12/9/10 - 08:22 pm
animal health
Bayer
Boehringer Ingelheim
Novartis
Merck
Sanofi
Pfizer's Mixed Bag
Motley Fool
Tue, 11/23/10 - 08:55 am
Pfizer
Apixaban
JNJ
Boehringer Ingelheim
Bristol-Myers Squibb
Axitinib
Names You Need To Know: Pradaxa and Xarelto
Forbes
Sat, 11/20/10 - 12:24 pm
Boehringer Ingelheim
Bayer
JNJ
Pradaxa
Xarelto
blood thinners
Top 15 Pharma R&D Budgets
Fierce Pharma
Thu, 11/18/10 - 08:47 am
R&D
Roche
Pfizer
Novartis
JNJ
Sanofi
GSK
Merck
Takeda
AstraZeneca
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Abbott Laboratories
Daiichi Sankyo
Astellas
Doctors say blood-clot drug race too close to call
Reuters
Tue, 11/16/10 - 11:59 am
blood thinners
Pradaxa
Xarelto
Bayer
JNJ
Boehringer Ingelheim
A Mega-Blockbuster Showdown
Motley Fool
Mon, 11/15/10 - 06:28 pm
Boehringer Ingelheim
Pradaxa
Bayer
Xarelto
JNJ
Boehringer Drug Lowers Bleeding Risk in Those Who Had Stroke
Bloomberg
Mon, 11/8/10 - 10:43 am
Boehringer Ingelheim
Pradaxa
blood thinners
stroke
Bayer rival Boehringer prices blood pill at $6.75
Reuters
Tue, 10/26/10 - 11:52 am
Bayer
Boehringer Ingelheim
drug pricing
anticlotting
JNJ
Pradaxa
Mylan gets US FDA nod for generic version of Mirapex tablets
Pharmabiz
Sat, 10/23/10 - 01:26 pm
Mylan
Mirapex
Boehringer Ingelheim
Parkinson's Disease
Boehringer Wins FDA Approval for First Warfarin Rival
Bloomberg
Tue, 10/19/10 - 06:46 pm
FDA
Boehringer Ingelheim
Warfarin
Bayer
Pradaxa
blood thinners
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Boehringer pulls plug on 'female Viagra' flibanserin
Pharma Times, UK
Fri, 10/8/10 - 08:15 am
flibanserin
female sexual dysfunction
Boehringer Ingelheim
Sanofi, Merck Said to Ready Sale of $1 Billion of Animal-Health Operations
Bloomberg
Fri, 10/1/10 - 10:11 am
Merck
Sanofi
animal health
M&A
Pfizer
Bayer
Boehringer Ingelheim
Eli Lilly
Novartis
U.S. panel backs Boehringer drug to reduce strokes
Reuters
Tue, 09/21/10 - 09:20 am
FDA
advisory panels
stroke
Boehringer Ingelheim
Pradaxa
blood thinners
Spiriva as good as Serevent in asthma study
Yahoo/AP
Mon, 09/20/10 - 11:00 am
Serevent
Spiriva
GSK
asthma
Teva Pharmaceuticals
Boehringer Ingelheim
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Seeking Alpha
Mon, 09/20/10 - 10:58 am
blood thinners
AstraZeneca
Bristol-Myers Squibb
Bayer
Eisai
Pfizer
Sanofi
Brilinta
Portola Pharmaceuticals
Boehringer Ingelheim
Bayer Chief Envisions $15 Billion Market for Xarelto, New Blood Thinners
Bloomberg
Thu, 09/16/10 - 12:29 pm
Bayer
Xarelto
blood thinners
anti-clotting
JNJ
Pfizer
Boehringer Ingelheim
Bristol-Myers Squibb
Pradaxa
FDA Asks For “Restraint” On Drug Safety Worries
Forbes
Thu, 09/9/10 - 05:47 pm
FDA
drug safety
Vioxx
Avandia
Merck
Pfizer
GSK
Spiriva
Boehringer Ingelheim
Pfizer, Bayer, Boehringer Bid to Replace Warfarin in Stroke-Drug Market
Bloomberg
Mon, 08/30/10 - 10:39 am
Pfizer
Bayer
Boehringer Ingelheim
Warfarin
Pradaxa
blood thinners

Pages